Fingerprint
Dive into the research topics of 'A phase III, multicenter, randomized study of olvimulogene nanivacirepvec followed by platinum-doublet chemotherapy and bevacizumab compared with platinum-doublet chemotherapy and bevacizumab in women with platinum-resistant/refractory ovarian cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically